Search

Recent breakthroughs in our understanding of anti-cancer immune responses has led to the development of an expanding generation of cancer immunotherapies, and a revolution in the treatment of cancer. Immunotherapies are designed... Read more

Immunotherapy of cancer has been a major breakthrough, now accepted as the fourth pillar of treatment after surgery, chemotherapy and radiotherapy. Immunotherapy is most effective in cancers with a high mutational burden and high... Read more

Following the wave of successful immunotherapy trials for the last 10 years, it is now clear there are a number of human cancer sub-types which are resistant to immunotherapy. This is frequently in patients with advanced... Read more

The Sherene Loi lab team is internationally recognised for their use of genomic and immunological approaches to understand mechanisms of breast cancer growth and drug resistance. The primary focus of the Sherene Loi lab is... Read more

Computational and statistical techniques are used to analyse and explore the transcriptome and genome. The group has a diverse and complementary skill set that includes statistics, computer science, genetics, software... Read more

Hepatocellular carcinoma (HCC) is the most common form of liver cancer and among the most fatal cancer types. Although the pathophysiology of HCC has not been fully elucidated, the process clearly arises in the context of chronic... Read more